<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Comparison of alpha and beta thalassemia pathophysiology and clinical features</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Comparison of alpha and beta thalassemia pathophysiology and clinical features</h1>
<div class="graphic"><div class="figure"><div class="ttl">Comparison of alpha and beta thalassemia pathophysiology and clinical features</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="33%"></colgroup> <tbody> <tr> <td class="subtitle1_left">Pathophysiology</td> <td class="subtitle1_left">Alpha thalassemia</td> <td class="subtitle1_left">Beta thalassemia</td> </tr> <tr> <td class="indent1">Genes affected</td> <td> <ul> <li>Alpha locus 1 and/or 2 </li> </ul> </td> <td> <ul> <li>Beta locus and sometimes delta locus </li> </ul> </td> </tr> <tr> <td class="indent1">Globin chains in excess</td> <td> <ul> <li>Gamma chains (fetus through early infancy), which form HbBarts* </li> <li>Beta chains (child and adult), which form HbH*  </li> <li>Beta chains can also form aggregates during erythropoiesis but to a lesser extent than free alpha chains  </li> </ul> </td> <td> <ul> <li>Alpha chains, which aggregate and precipitate, beginning early in erythropoiesis* </li> <li>Some alpha chains persist in circulating RBCs as inclusion bodies </li> </ul> </td> </tr> <tr> <td class="indent1">Effect on RBCs and erythroblasts</td> <td> <ul> <li>Membrane damage </li> <li>Hyperhydration </li> </ul> </td> <td> <ul> <li>Membrane damage </li> <li>Dehydration </li> </ul> </td> </tr> <tr class="divider_bottom"> <td class="indent1">Mechanisms of anemia<sup>¶</sup></td> <td> <ul> <li>Peripheral blood hemolysis predominates </li> <li>Component of ineffective erythropoiesis </li> </ul> </td> <td> <ul> <li>Ineffective erythropoiesis predominates </li> <li>Component of peripheral blood hemolysis </li> </ul> </td> </tr> <tr> <td class="subtitle1_left" colspan="3">Clinical features</td> </tr> <tr> <td class="indent1">Geographic origins</td> <td> <ul> <li>Malaria belt<sup>Δ</sup> </li> </ul> </td> <td> <ul> <li>Malaria belt<sup>Δ</sup> </li> </ul> </td> </tr> <tr> <td class="indent1">Age of onset</td> <td> <ul> <li>Before birth </li> </ul> </td> <td> <ul> <li>6 to 9 months </li> </ul> </td> </tr> <tr> <td class="indent1">Physical findings</td> <td> <ul> <li>Pallor and jaundice </li> <li>Growth retardation </li> <li>Bony and facial deformities (lesser in alpha thalassemia than beta thalassemia) </li> <li>Hepatosplenomegaly </li> </ul> </td> <td> <ul> <li>Pallor and jaundice </li> <li>Growth retardation </li> <li>Bony and facial deformities (more in beta thalassemia than in alpha thalassemia) </li> <li>Hepatosplenomegaly </li> </ul> </td> </tr> <tr> <td class="indent1">CBC and blood smear</td> <td> <ul> <li>Findings consistent with hemolytic anemia<sup>◊</sup> </li> <li>Microcytosis and hypochromia </li> <li>Anisocytosis and poikilocytosis </li> </ul> </td> <td> <ul> <li>Findings consistent with hemolytic anemia<sup>◊</sup> </li> <li>Microcytosis and hypochromia </li> <li>Anisocytosis and poikilocytosis </li> <li>NRBCs </li> </ul> </td> </tr> <tr> <td class="indent1">Complications</td> <td> <ul> <li>Iron overload and associated organ damage (with or without transfusions) </li> <li>Extramedullary hematopoiesis </li> <li>VTE </li> <li>Leg ulcers </li> <li>Pathologic fractures (less-so in alpha than in beta thalassemia) </li> </ul> </td> <td> <ul> <li>Iron overload and associated organ damage (with or without transfusions) </li> <li>Extramedullary hematopoiesis </li> <li>VTE </li> <li>Leg ulcers </li> <li>Pathologic fractures (more-so in beta than in alpha thalassemia) </li> </ul> </td> </tr> </tbody></table></div><div class="graphic_lgnd">The severity of all of these features depends on how many of the globin genes are affected (<font color="black">beta thalassemia: 1 or 2; alpha thalassemia: 1, 2, 3, or 4) and the specific variant(s) within the affected gene(s). Persistence of HbF after birth can mitigate the clinical severity of beta thalassemia. Refer to UpToDate for additional information.</font></div><div class="graphic_footnotes">HbH: hemoglobin H; RBCs: red blood cells; CBC: complete blood smear: NRBC: nucleated red blood cells; VTE: venous thromboembolism.<br/>* HbBarts (tetramers of gamma<font color="black"> globin) and HbH (tetramers of beta globin) are somewhat soluble homotetrameric hemoglobins that behave like unstable hemoglobins. They bind oxygen but cannot release it to tissues. Unpaired alpha chains cannot form hemoglobin and instead aggregate and form insoluble precipitates.<br/>¶ Alpha and beta thalassemia both have components of ineffective erythropoiesis and peripheral blood hemolysis.<br/>Δ The malaria belt consists of tropical and </font>subtropical regions in which malaria is (or was) endemic, including the Mediterranean basin, Africa, the Middle East, and Southern Asia.<br/><font class="lozenge">◊</font> In addition to anemia, hemolysis can cause low haptoglobin, increased lactate dehydrogenase (LDH), increased indirect bilirubin, and increased reticulocyte count.</div><div id="graphicVersion">Graphic 130100 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
